
Trump outlines phased tariffs on generic drugs, India's exports at risk
The story in brief
US President Trump announced a phased tariff regime on imported generic medicines starting Aug. 2028, aiming to reshift pharmaceutical manufacturing to the US. India, the world's largest supplier and top US exporter, faces potential tariffs. The policy, still in progress, includes zero tariffs for two years from Aug. 1, 2026, before sharp increases. The administration also plans new tariffs on imports from 60 countries, including India.